Colorescience Reveals Clinical Study Results of the Finishing Touch™ Skincare Protocol Following Facial Radiofrequency Microneedling Procedures May 27, 2022
Werewolf Therapeutics Reports First Quarter 2022 Financial Results and Provides Business Highlights May 11, 2022
TScan Therapeutics Reports First Quarter 2022 Financial Results and Upcoming Anticipated Milestones May 10, 2022
ARCH leads $130M infusion into Be Bio’s long pursuit of B cell therapies for rare disease, cancer April 14, 2022
